Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

DNA Genetics

Explore full profile

DNA Genetics a globally recognized leading cannabis brand

Amsterdam, NetherlandsFounded 2004Health
Valuation $100–250M Last recorded · 2018
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for DNA Genetics and the history behind them.

About DNA Genetics

DNA Genetics operates as a distinguished producer and distributor in the cannabis market, specializing in the genetic selection, breeding, and cultivation of medicinal and recreational cannabis. The company was founded in 2004 in Amsterdam by Don Morris and Aaron Yarkoni, both originally from California. They relocated to the Netherlands to leverage the legal cannabis market, bringing with them Californian hybrid strains to establish their seed bank. Morris and Yarkoni's passion for cannabis and a vision for a global cannabis culture have been central to the company's trajectory, establishing a brand recognized for its quality genetics.

Read full description

The company's business model is centered on providing high-quality cannabis seeds and genetics to a global market. Revenue is generated through the sale of feminized, regular, and autoflower cannabis seeds directly to consumers and through a wholesale program. Beyond seed sales, DNA Genetics engages in licensing agreements and strategic partnerships with cultivators and distributors in legal markets worldwide, such as in Canada, the US, and Europe. These partnerships often involve providing partners with their proprietary strains and cultivation expertise, allowing them to produce certified DNA Genetics products. The company also generates revenue from consulting services for other industry professionals and government organizations, as well as the sale of branded merchandise and apparel.

DNA Genetics serves both the recreational and medicinal cannabis sectors. Its primary clients are individual growers, commercial cultivators, and distributors in legal cannabis markets across North America and Europe. Through strategic alliances with companies like Canopy Growth Corporation, Revolutionary Clinics, and Halo Labs, DNA Genetics has established a significant footprint in various regions, including Canada, Jamaica, and several US states like Colorado, Nevada, and Arizona. One notable milestone was the acquisition of Crockett Family Farms in 2019, which brought the highly-awarded Tangie strain into its portfolio. The company has received over 200 awards for its strains, including multiple High Times Cannabis Cups, underscoring its reputation in the industry.

The product portfolio consists of a wide variety of cannabis strains known for their quality and stability, available as seeds. Famous strains include L.A. Confidential, Chocolope, Kosher Kush, and Tangie. These products are developed through meticulous genetic selection and breeding to ensure distinct terpene profiles and consistent quality. The company offers a germination guarantee for its seeds and operates a customer loyalty program. Beyond its core seed business, DNA Genetics' product line, through its partners, extends to indoor-grown dry flower, pre-rolled joints, and vaporizer cartridges.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2004
Headquarters
Amsterdam, Netherlands
Open positions
None listed
Dealroom signal
19.0/100
Industry
Health
Sector
Health, DNA, Genetics and genomics, Cannabis, Genome Engineering, Hard Tech
Client focus
b2b

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC Dec 2018 $35M $140M KES 7 Capital —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

DNA Genetics website traffic

Latest recorded traffic for DNA Genetics is 35K monthly website visits, down 36.4% over the last three months.

Latest monthly visits35K 3-month web change-36.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • KES 7 Capital
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇳🇱 Netherlands · Amsterdam HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about DNA Genetics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See DNA Genetics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.